WOCKHARDT
Back to Balance Sheet
|
WOCKHARDT Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-440 Cr | ₹-514 Cr | ₹-544 Cr | ₹-576 Cr | ₹-545 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of WOCKHARDT ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹-440 Cr |
| Mar2025 | ₹-514 Cr |
| Mar2024 | ₹-544 Cr |
| Mar2023 | ₹-576 Cr |
| Mar2022 | ₹-545 Cr |
How is Deferred Tax Assets / Liabilities of WOCKHARDT Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-440 Cr | Negative | |
| Mar2025 | ₹-514 Cr | Negative | |
| Mar2024 | ₹-544 Cr | Negative | |
| Mar2023 | ₹-576 Cr | Negative | |
| Mar2022 | ₹-545 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of WOCKHARDT
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WOCKHARDT | ₹32,061.3 Cr | 0.7% | 8.1% | 19.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹466,431.0 Cr | -2.3% | 3% | 12.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹220,115.0 Cr | 2.9% | 22.7% | 25.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,853.0 Cr | -2.7% | 2% | 33.9% | Stock Analytics | |
| CIPLA | ₹119,158.0 Cr | 0.1% | 3% | -7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.4 Cr | 2.4% | -12.9% | -9.1% | Stock Analytics | |
WOCKHARDT Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WOCKHARDT | 0.7% |
8.1% |
19.7% |
| SENSEX | 1.3% |
1% |
-2.9% |
You may also like the below Video Courses